The DOI matches its Crossref record; 69 of the 69 references it cites were found in a registry or an index.
Clinical Prevalence, Antimicrobial Susceptibility, and Geographic Resistance Patterns of Enterococci: Results from the SENTRY Antimicrobial Surveillance Program, 1997–1999
Abstract
As part of the SENTRY Antimicrobial Resistance Surveillance Program, a total of 4998 strains of enterococci isolated from 1997 to 1999 were processed. The occurrence of enterococcal infections by species and site of infection was analyzed, as were the occurrence of vancomycin-resistant enterococci (VRE) and their resistance phenotypes and genotypes. Trends in antimicrobial susceptibility to a variety of agents (including experimental compounds) were also reported. Enterococci accounted for >9% of isolates from all bloodstream infections (BSIs) in North America. Ampicillin was active against strains from Latin America and Europe but not against those from the United States and Canada. US isolates were considerably more resistant to vancomycin (17% resistant strains in 1999) than were those from patients in the rest of the world. The highest proportion of VRE was observed among BSI isolates (81.7%). Quinupristin-dalfopristin, chloramphenicol, and doxycycline were the most active agents tested against VRE. The results of this study confirm the worldwide trend in increasing occurrence of enterococci and the emerging pattern of antimicrobial resistance among such isolates.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically
Ferraro, M. J. (2000) · Cited by 16,875
Manual of Clinical Microbiology.
(1980) · Annals of Internal Medicine · doi:10.7326/0003-4819-93-6-939_2 · Cited by 14,411
Principles and Practice of Infectious Diseases.
(1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-9-818_5 · Cited by 12,025
Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility
Hiramatsu, K. (1997) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/40.1.135 · Cited by 1,984
Dutka-Malen, S., Evers, S., & Courvalin, P. (1995) · Journal of Clinical Microbiology · doi:10.1128/jcm.33.1.24-27.1995 · Cited by 1,403
Nosocomial Bloodstream Infections in United States Hospitals: A Three‐Year Analysis
Edmond, M. B., Wallace, S. E., McClish, D. K., Pfaller, M. A., Jones, R. N., & Wenzel, R. P. (1999) · Clinical Infectious Diseases · doi:10.1086/520192 · Cited by 1,387
Self-citationAn overview of nosocomial infections, including the role of the microbiology laboratory
Emori, T. G., & Gaynes, R. P. (1993) · Clinical Microbiology Reviews · doi:10.1128/cmr.6.4.428 · Cited by 1,286
VANCOMYCIN-RESISTANT ENTEROCOCCI
Uttley, A. C., Collins, C. H., Naidoo, J., & George, R. C. (1988) · The Lancet · doi:10.1016/s0140-6736(88)91037-9 · Cited by 1,226
Major trends in the microbial etiology of nosocomial infection
Schaberg, D. R., Culver, D. H., & Gaynes, R. P. (1991) · The American Journal of Medicine · doi:10.1016/0002-9343(91)90346-y · Cited by 1,109
Guideline for Isolation Precautions in Hospitals
Garner, J. S., & Hospital Infection Control Practices Advisory Committee (1996) · Infection Control & Hospital Epidemiology · doi:10.1086/647190 · Cited by 1,068
Guideline for Isolation Precautions in Hospitals
Garner, J. S., & the Hospital Infection Control Practices Advisory Committee (1996) · Infection Control & Hospital Epidemiology · doi:10.1017/s0195941700006123 · Cited by 994
Identification of Enterococcus species isolated from human infections by a conventional test scheme
Facklam, R. R., & Collins, M. D. (1989) · Journal of Clinical Microbiology · doi:10.1128/jcm.27.4.731-734.1989 · Cited by 791
(1995) · American Journal of Infection Control · doi:10.1016/0196-6553(95)90104-3 · Cited by 709
Noble, W. C., Virani, Z., & Cree, R. G. A. (1992) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.1992.tb05089.x · Cited by 627
Guideline for Isolation Precautions in Hospitals
Garner, J. S. (1996) · Infection Control and Hospital Epidemiology · doi:10.2307/30142367 · Cited by 590
Emergence of Vancomycin Resistance in Coagulase-Negative Staphylococci
Schwalbe, R. S., Stapleton, J. T., & Gilligan, P. H. (1987) · New England Journal of Medicine · doi:10.1056/nejm198704093161507 · Cited by 584
Pfaller, M. A., Jones, R. N., Doern, G. V., Kugler, K., & Group, T. S. P. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.7.1762 · Cited by 539
Self-citationManual of clinical microbiology
Murray, P. R., Versalovic, J., & Jorgensen, J. H. (1999) · Cited by 499
Morris, J. G., Shay, D. K., Hebden, J. N., McCarter, R. J., Perdue, B. E., Jarvis, W., Johnson, J. A., Dowling, T. C., Polish, L. B., & Schwalbe, R. S. (1995) · Annals of Internal Medicine · doi:10.7326/0003-4819-123-4-199508150-00002 · Cited by 489
Boyce, J. M., Opal, S. M., Chow, J. W., Zervos, M. J., Potter-Bynoe, G., Sherman, C. B., Romulo, R. L., Fortna, S., & Medeiros, A. A. (1994) · Journal of Clinical Microbiology · doi:10.1128/jcm.32.5.1148-1153.1994 · Cited by 485
Farm animals as a putative reservoir for vancomycin-resistant enterococcal infection in man
Bates, J., Jordens, J. Z., & Griffiths, D. T. (1994) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/34.4.507 · Cited by 420
Vancomycin-Resistant Enterococcal Bacteremia: Natural History and Attributable Mortality
Edmond, M. B., Ober, J. F., Dawson, J. D., Weinbaum, D. L., & Wenzel, R. P. (1996) · Clinical Infectious Diseases · doi:10.1093/clinids/23.6.1234 · Cited by 301
Current perspectives on glycopeptide resistance
Woodford, N., Johnson, A. P., Morrison, D., & Speller, D. C. (1995) · Clinical Microbiology Reviews · doi:10.1128/cmr.8.4.585 · Cited by 298
Diversity among Multidrug-Resistant Enterococci
Murray, B. E. (1998) · Emerging Infectious Diseases · doi:10.3201/eid0401.980106 · Cited by 285
Vancomycin-resistant enterococci from nosocomial, community, and animal sources in the United States
Coque, T. M., Tomayko, J. F., Ricke, S. C., Okhyusen, P. C., & Murray, B. E. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.11.2605 · Cited by 279
Historical Yearly Usage of Vancomycin
Kirst, H. A., Thompson, D. G., & Nicas, T. I. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.5.1303 · Cited by 276
Klare, I., Heier, H., Claus, H., BÖHME, G., Marin, S., Seltmann, G., Hakenbeck, R., Antanassova, V., & Witte, W. (1995) · Microbial Drug Resistance · doi:10.1089/mdr.1995.1.265 · Cited by 262
Linden, P. K., Pasculle, A. W., Manez, R., Kramer, D. J., Fung, J. J., Pinna, A. D., & Kusne, S. (1996) · Clinical Infectious Diseases · doi:10.1093/clinids/22.4.663 · Cited by 259
Resistance to vancomycin and teicoplanin: an emerging clinical problem
Johnson, A. P., Uttley, A. H., Woodford, N., & George, R. C. (1990) · Clinical Microbiology Reviews · doi:10.1128/cmr.3.3.280 · Cited by 245
VanD-type glycopeptide-resistant Enterococcus faecium BM4339
Perichon, B., Reynolds, P., & Courvalin, P. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.9.2016 · Cited by 244
Pfaller, M. A., Jones, R. N., Doern, G. V., Sader, H. S., Kugler, K. C., & Beach, M. L. (1999) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(98)00149-7 · Cited by 243
Self-citationVanE, a New Type of Acquired Glycopeptide Resistance in Enterococcus faecalis BM4405
Fines, M., Perichon, B., Reynolds, P., Sahm, D. F., & Courvalin, P. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.9.2161 · Cited by 241
Resistance to Glycopeptides in Enterococci
Leclercq, R., & Courvalin, P. (1997) · Clinical Infectious Diseases · doi:10.1093/clind/24.4.545 · Cited by 239
Gordon, S., Swenson, J. M., Hill, B. C., Pigott, N. E., Facklam, R. R., Cooksey, R. C., Thornsberry, C., Jarvis, W. R., & Tenover, F. C. (1992) · Journal of Clinical Microbiology · doi:10.1128/jcm.30.9.2373-2378.1992 · Cited by 237
Boyle, J. F., Soumakis, S. A., Rendo, A., Herrington, J. A., Gianarkis, D. G., Thurberg, B. E., & Painter, B. G. (1993) · Journal of Clinical Microbiology · doi:10.1128/jcm.31.5.1280-1285.1993 · Cited by 217
McDonald, L. C., Kuehnert, M. J., Tenover, F. C., & Jarvis, W. R. (1997) · Emerging Infectious Diseases · doi:10.3201/eid0303.970307 · Cited by 206
The epidemiology of intravenous vancomycin usage in a university hospital. A 10-year study
Ena, J. (1993) · JAMA · doi:10.1001/jama.269.5.598 · Cited by 203
Grayson, M. L., Eliopoulos, G. M., Wennersten, C. B., Ruoff, K. L., De Girolami, P. C., Ferraro, M. J., & Moellering, R. C. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.11.2180 · Cited by 195
Faecal carriage and nosocomial spread of vancomycin-resistant Enterococcus faecium
Jordens, J. Z., Bates, J., & Griffiths, D. T. (1994) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/34.4.515 · Cited by 194
Resistance of enterococci to glycopeptides
Courvalin, P. (1990) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.34.12.2291 · Cited by 189
Beta-lactamase-producing enterococci
Murray, B. E. (1992) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.36.11.2355 · Cited by 182
Vancomycin resistance gene vanC is specific to Enterococcus gallinarum
Leclercq, R., Dutka-Malen, S., Duval, J., & Courvalin, P. (1992) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.36.9.2005 · Cited by 174
Vancomycin‐Resistant Enterococci
Moellering, Jr. (1998) · Clinical Infectious Diseases · doi:10.1086/520283 · Cited by 173
Jones, R. N. (1996) · The American Journal of Medicine · doi:10.1016/s0002-9343(96)00102-7 · Cited by 171
Self-citationPoyart, C., Pierre, C., Quesne, G., Pron, B., Berche, P., & Trieu-Cuot, P. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.1.24 · Cited by 168
Vancomycin-Resistant Enterococci in Turkeys and Farmers
van den Bogaard, A. E., Jensen, L. B., & Stobberingh, E. E. (1997) · New England Journal of Medicine · doi:10.1056/nejm199711203372117 · Cited by 168
Endtz, H. P., van den Braak, N., van Belkum, A., Kluytmans, J. A., Koeleman, J. G., Spanjaard, L., Voss, A., Weersink, A. J., Vandenbroucke-Grauls, C. M., Buiting, A. G., et al. (1997) · Journal of Clinical Microbiology · doi:10.1128/jcm.35.12.3026-3031.1997 · Cited by 162
Jones, R. N., Ballow, C. H., Biedenbach, D. J., Deinhart, J. A., & Schentag, J. J. (1998) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(98)80002-3 · Cited by 160
Self-citationJones, R. N., Marshall, S. A., Pfaller, M. A., Wilke, W. W., Hollis, R. J., Erwin, M. E., Edmond, M. B., & Wenzel, R. P. (1997) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(97)00115-6 · Cited by 153
Self-citationJones, R. N., Kugler, K. C., Pfaller, M. A., & Winokur, P. L. (1999) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(98)00158-8 · Cited by 151
Self-citationBacterial Resistance: A Worldwide Problem
Jones, R. N., & Pfaller, M. A. (1998) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(98)00037-6 · Cited by 145
Self-citationJones, R. N., Sader, H. S., Erwin, M. E., et al. (1995) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/0732-8893(94)00147-o · Cited by 140
Self-citationDoern, G. V., Jones, R. N., Pfaller, M. A., Kugler, K. C., & Beach, M. L. (1999) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(98)00162-x · Cited by 140
Self-citationJones, R. N., Johnson, D. M., & Erwin, M. E. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.3.720 · Cited by 128
Self-citationJones, R., Low, D., & Pfaller, M. A. (1999) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(98)00108-4 · Cited by 126
Self-citationManagement of infections due to resistant enterococci: a review of therapeutic options
Landman, D. (1997) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/40.2.161 · Cited by 121
Mechanisms of glycopeptide resistance in enterococci
Arthur, M., Reynolds, P. E., Depardieu, F., Evers, S., Dutka‐Malen, S., Quintiliani, R., & Courvalin, P. M. (1996) · Journal of Infection · doi:10.1016/s0163-4453(96)80003-x · Cited by 116
Tenover, F. C., Swenson, J. M., O'Hara, C. M., & Stocker, S. (1995) · Journal of Clinical Microbiology · doi:10.1128/jcm.33.6.1524-1527.1995 · Cited by 113
Enterococci and Vancomycin Resistance
French, G. L. (1998) · Clinical Infectious Diseases · doi:10.1086/514910 · Cited by 110
Gambarotto, K., Ploy, M.-C., Turlure, P., Grélaud, C., Martin, C., Bordessoule, D., & Denis, F. (2000) · Journal of Clinical Microbiology · doi:10.1128/jcm.38.2.620-624.2000 · Cited by 108
The emergent needs for basic research, education, and surveillance of antimicrobial resistance
Jones, R. N. (1996) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(96)00099-5 · Cited by 105
Self-citationPower, E. G. M., Abdulla, Y. H., Talsania, H., Spice, W. M., Aathithan, S., & French, G. L. (1995) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/36.4.595 · Cited by 95
Enterococci highly resistant to penicillin and ampicillin: an emerging clinical problem?
Sapico, F. L., Canawati, H. N., Ginunas, V. J., et al. (1989) · Journal of Clinical Microbiology · doi:10.1128/jcm.27.9.2091-2095.1989 · Cited by 92
Spread of Vancomycin-Resistant Enterococci: Differences Between the United States and Europe
Goossens, H. (1998) · Infection Control and Hospital Epidemiology · doi:10.1086/647871 · Cited by 84
Evaluation and characterization of multiresistant Enterococcus faecium from 12 U.S. medical centers
Sader, H. S., Pfaller, M. A., Tenover, F. C., Hollis, R. J., & Jones, R. N. (1994) · Journal of Clinical Microbiology · doi:10.1128/jcm.32.11.2840-2842.1994 · Cited by 82
Self-citationVancomycin‐ResistantStaphylococcus aureus: Infection Control Considerations
Wenzel, R. P., & Edmond, M. B. (1998) · Clinical Infectious Diseases · doi:10.1086/514646 · Cited by 70
Caron, F., Gold, H. S., Wennersten, C. B., Farris, M. G., Moellering, R. C., & Eliopoulos, G. M. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.12.2749 · Cited by 41
Surveillance of the current resistance of nosocomial pathogens to antibacterials
Spencer, R. C., Bauernfeind, A., García‐Rodríguez, J., Jarlier, V., Pfaller, M. A., Turnidge, J. D., & Voß, A. (1997) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.1997.tb00644.x · Cited by 37
Wilke, W. W., Marshall, S. A., Coffman, S. L., et al. (1997) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(97)00059-x · Cited by 37
Cited by
Phillips, I. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg483 · Cited by 1,100
DiazGranados, C. A., Zimmer, S. M., Mitchel, K., & Jernigan, J. A. (2005) · Clinical Infectious Diseases · doi:10.1086/430909 · Cited by 459
Favorable Impact of a Multidisciplinary Antibiotic Management Program Conducted During 7 Years
Carling, P., Fung, T., Killion, A., Terrin, N., & Barza, M. (2003) · Infection Control & Hospital Epidemiology · doi:10.1086/502278 · Cited by 405
Breakthroughs in bacterial resistance mechanisms and the potential ways to combat them
Khameneh, B., Diab, R., Ghazvini, K., & Fazly Bazzaz, B. S. (2016) · Microbial Pathogenesis · doi:10.1016/j.micpath.2016.02.009 · Cited by 345
Emergence of CC17 Enterococcus faecium: from commensal to hospital-adapted pathogen
Top, J., Willems, R., & Bonten, M. (2008) · FEMS Immunology & Medical Microbiology · doi:10.1111/j.1574-695x.2008.00383.x · Cited by 260
Metadata
- Authors
- Low, D. E., Keller, N., Barth, A., & Jones, R. N.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2001-05-15
- Volume
- 32
- Issue
- s2
- Pages
- S133-S145
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2126524876
- Cited by
- 289
- References
- 69
- FWCI
- 11.52
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.